Imunon announces six-month data showing durability of protection for next-generation dna vaccine platform in phase 1 clinical trial in covid-19

Company's placcine® technology platform demonstrates better durability and other advantages compared to mrna vaccines

DNA Ratings Summary

DNA Quant Ranking